Ching-Lee Fukuda is a New York-based partner in Morrison Foerster’s Intellectual Property Litigation Group and a nationally recognized intellectual property (IP) trial lawyer, with nearly three decades of experience handling high-stakes patent and trade secret litigation. She represents clients in complex IP disputes before federal district courts, the International Trade Commission, PTAB, the Federal Circuit, and various arbitration tribunals.

Ching-Lee’s practice focuses on cutting-edge technologies in medical devices and medtech, software, electronics, and chemicals. She has secured significant trial and appellate victories, including high-value jury verdicts and precedent-setting Federal Circuit decisions:

• Ching-Lee led a damages trial team for Bayer that secured a jury award of $155 million, which ranks among the top 10 largest patent verdicts in Delaware.
  
• She successfully defended Nevro in a six-year litigation saga against Boston Scientific’s assertion of 20 patents and more than 60 trade secrets, with Boston Scientific ultimately paying Nevro $85 million.
  
• She led an appellate team for CardioNet that obtained a rare Federal Circuit precedential opinion reversing the district court to uphold the patent eligibility of a software patent directed to cardiac monitoring technology.
  

Ching-Lee has also led IP arbitration teams and has handled more than 100 PTAB proceedings, including inter partes reviews (IPRs) and post-grant reviews (PGRs), representing both patent owners and challengers.

In addition to her litigation practice, Ching-Lee is a frequent speaker and author on IP issues, particularly in the life sciences and technology sectors. She also holds leadership roles in organizations focused on inclusion and professional development in IP law. Clients highlight Ching-Lee’s formidable courtroom presence and sharp analytical approach, emphasizing her ability to deliver successful outcomes in particularly challenging matters. Beyond her Chambers USA and Chambers Global recognitions, she has received a range of industry honors, including the following:

• Named Patent Lawyer of the Year by Women in Business Law Americas in 2024.
  
• Repeatedly shortlisted by Managing IP for Litigator of the Year – New York.
  
• Recognized by LMG Life Sciences as Post-Grant Proceedings Attorney of the Year in multiple years.
  
• Earned several Impact Case of the Year distinctions and inclusion in the National Law Journal Verdicts Hall of Fame (2021) and Top 10 Commercial Litigation Verdicts in the United States (2019).
  

Ching-Lee earned her J.D. from Fordham University School of Law and her B.S.E., with honors, in mechanical and aerospace engineering, from Princeton University.